ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in December 2020. Updated January 4.
A roundup of FDA’s actions in December 2020.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in December 2020. Updated January 4.
A roundup of FDA’s actions in December 2020.